Nan Fung Group Holdings’s Travere Therapeutics TVTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-25,606	Closed	-$576K	–	47
2023 Q1	$576K	Hold	25,606	–	–	0.39%	31
2022 Q4	$538K	Buy	+25,606	New	+$538K	0.37%	26
2022 Q1	–	Sell	-48,500	Closed	-$1.51M	–	57
2021 Q4	$1.51M	Buy	+48,500	New	+$1.51M	0.45%	22